Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Bullboard - Stock Discussion Forum Trillium Therapeutics Inc. T.TRIL

Trillium Therapeutics Inc is a clinical-stage immuno-oncology company that is engaged in developing therapies for the treatment of cancer. It has two clinical programs, TTI-621 and TTI-622, that target CD47. The company operates in the United States and Canada.

TSX:TRIL - Post Discussion

Trillium Therapeutics Inc. > Been holding up well
View:
Post by CleverInvestor2 on Mar 26, 2020 11:09pm

Been holding up well

During Covid-19 pandemic, tril has dropped big time but slowly going back up. Overall, has performed well in this pandemic.

Fundamentals are still there, lots of cash in the bank and big news coming out around June.
Until May, I see this going up to new ATH. Late May/June you'll see some profit taking and the price will drop.... and than it's the moment of truth. Will we head towards $20 or down to $4?
Comment by burnout29 on Apr 08, 2020 9:06am
This post has been removed in accordance with Community Policy
Comment by CleverInvestor2 on Apr 12, 2020 9:27pm
https://ir.trilliumtherapeutics.com/press-releases/press-release-details/2020/Trillium-Therapeutics-Provides-Business-Update-in-Response-to-the-Covid-19-Pandemic-/default.aspx Check it out. They came out with a NR to assure investors that everything was still progressing as expected. Lots of cash in the bank to last until 2022, an update to be relased by Summer for the progress of the CD47, etc ...more  
Comment by burnout29 on Apr 13, 2020 9:03am
This post has been removed in accordance with Community Policy
Comment by birch1 on Apr 13, 2020 4:16pm
so am I.  Good trading should continue to go up.  Wondering if there is something up.
Comment by burnout29 on Apr 13, 2020 6:31pm
This post has been removed in accordance with Community Policy
Comment by birch1 on Apr 14, 2020 10:07am
yeah.  wonder if we get a buyout.
Comment by CleverInvestor2 on Apr 14, 2020 10:27am
It looks like we're going to be making another run up like earlier this year. The momentum is back and investors like good buisness plans and strong healthy financial sheets. Trillium has enough money to last them until 2022. By then we should have a clear picture if trillium is a winner or not. If it's a winner, we can get another PP at much higher values to keep us afloat or.... Possible ...more  
Comment by birch1 on Apr 14, 2020 10:45am
yup.  Nice volume again.
Comment by burnout29 on Apr 21, 2020 5:08pm
This post has been removed in accordance with Community Policy
Comment by birch1 on Apr 22, 2020 1:13pm
sometimes silence is golden.
The Market Update
{{currentVideo.title}} {{currentVideo.relativeTime}}
< Previous bulletin
Next bulletin >

At the Bell logo
A daily snapshot of everything
from market open to close.

{{currentVideo.companyName}}
{{currentVideo.intervieweeName}}{{currentVideo.intervieweeTitle}}
< Previous
Next >
Dealroom for high-potential pre-IPO opportunities